A personalized vaccine for patients with glioblastoma produced a safe and effective immune response, according to a study published May 12 in Nature Cancer. A phase 1 clinical trial of the vaccine was conducted at St. Louis-based Siteman Cancer Center…
Pharmacy
The FDA is seeking public input on drug repurposing efforts aimed at expanding treatment options for diseases tied to unmet medical needs. The agency said identifying new uses for FDA-approved drugs could accelerate treatment availability by relying on existing safety…
Use of manufacturer-sponsored coupons for brand-name drugs declined among commercially insured patients between 2017 and 2024, even as the value of coupon offsets increased, according to a study published April 6 in JAMA. The study analyzed pharmacy claims data from…
Hospital pharmacy has quietly become one of healthcare’s most data-intensive divisions. Pharmacy teams analyze controlled substance movement to detect drug diversion, optimize drug spending, monitor shortages to plan purchasing and clinical strategies, and ensure that every high-cost drug in decentralized…
Breast cancer patients with obesity or Type 2 diabetes who used GLP-1s had lower all-cause mortality and risk of recurrence, according to a study published May 11 in JAMA Network Open. Researchers from Richmond, Va.-based VCU Massey Comprehensive Cancer Center…
Advertisement
Pharmacy leaders across major health systems say one set of changes would do more than anything else to expand pharmacy’s role in care delivery: Remove the regulatory and reimbursement barriers that prevent pharmacists from practicing at the top of their…
The FDA has approved Bizengri for adults with advanced, unresectable or metastatic cholangiocarcinoma harboring a neuregulin 1 gene fusion whose disease progressed on or after prior systemic therapy. Bizengri is the first approved treatment for patients with NRG1 fusion-positive cholangiocarcinoma,…
The FDA has issued guidance outlining recommendations for studying the safety of drugs and biologics used during pregnancy after products receive approval. The guidance describes several methodologies drugmakers can use in postapproval settings to collect pregnancy safety data, including pregnancy…
The FDA has outlined a potential path forward for resubmission of the biologics license application for tabelecleucel, an investigational T-cell therapy for Epstein-Barr virus-positive post-transplant lymphoproliferative disease. During a meeting, the FDA told the drugmaker that a single-arm study using…
The American Society of Health‑System Pharmacists has partnered with HOSA-Future Health Professionals to introduce middle and high school students to careers in hospital and health system pharmacy. The collaboration builds on the ASHP’s We’re Your Pharmacist public awareness campaign, which…